cefodizime has been researched along with Chronic Illness in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (28.57) | 18.7374 |
1990's | 5 (71.43) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Freiesleben, H; Herhahn, D; Marre, R; Sack, K; Schulz, E | 1 |
Dagrosa, EE; Ringoir, SM; Van Landschoot, N; Vanholder, R; Waterloos, MA | 1 |
Cocuzza, G; Zanussi, C | 1 |
Costongs, RJ; Davies, BI; Geraedts, WH; Gubbelmans, HL; Maesen, FP; Meek, JC; van den Bergh, JJ | 1 |
Ringoir, S; Vanholder, R | 1 |
Davies, BI; Geraedts, WH; Gubbelmans, HL; Maesen, FP; Meek, JC; van den Bergh, JJ | 1 |
Baur, C; Davies, BI; Maesen, FP; Sumajow, CA | 1 |
3 trial(s) available for cefodizime and Chronic Illness
Article | Year |
---|---|
Antibiotics and energy delivery to the phagocytosis-associated respiratory burst in chronic hemodialysis patients: a comparison of cefodizime and cotrimoxazole.
Topics: Adult; Aged; Cefotaxime; Chronic Disease; Dose-Response Relationship, Drug; Energy Metabolism; Female; Glycolysis; Humans; Injections, Intravenous; Latex; Male; Middle Aged; NADH, NADPH Oxidoreductases; NADPH Oxidases; Neutrophils; Phagocytes; Phagocytosis; Renal Dialysis; Respiratory Burst; Time Factors; Trimethoprim, Sulfamethoxazole Drug Combination; Uremia; Zymosan | 1993 |
Open, controlled, randomized study on the efficacy and safety of cefodizime single daily dose versus two daily doses and versus ceftriaxone single daily dose in patients with acute purulent bronchitis and acute purulent exacerbation of chronic bronchitis.
Topics: Acute Disease; Bronchitis; Cefotaxime; Ceftriaxone; Cephalosporins; Chronic Disease; Drug Administration Schedule; Female; Humans; Injections, Intramuscular; Male | 1995 |
Cefodizime and cefotaxime in acute exacerbations of chronic bronchitis: a randomized double-blind prospective study in 180 patients.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Bronchitis; Cefotaxime; Chronic Disease; Double-Blind Method; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Prospective Studies; Randomized Controlled Trials as Topic; Sputum | 1990 |
4 other study(ies) available for cefodizime and Chronic Illness
Article | Year |
---|---|
Ceftazidime, ceftizoxime, cefotaxime and HR 221 in experimental chronic Escherichia coli pyelonephritis in rats.
Topics: Animals; Cefotaxime; Ceftazidime; Ceftizoxime; Cephalosporins; Chronic Disease; Drug Evaluation, Preclinical; Escherichia coli Infections; Pyelonephritis; Rats | 1983 |
Clinical and bacteriological experience with cefodizime in acute purulent exacerbations of chronic bronchitis.
Topics: Aged; Bacteria; Bronchitis; Cefotaxime; Chronic Disease; Female; Humans; Male; Middle Aged; Sputum; Suppuration | 1992 |
Cefodizime: enhancement of depressed phagocytosis-associated respiratory burst activity in chronic uremic patients.
Topics: Cefotaxime; Chronic Disease; Humans; Phagocytosis; Respiratory Burst; Uremia | 1992 |
Cefodizime in acute purulent exacerbations of chronic respiratory disease.
Topics: Adult; Aged; Aged, 80 and over; Cefotaxime; Chronic Disease; Female; Humans; Kinetics; Male; Microbial Sensitivity Tests; Middle Aged; Respiratory Tract Diseases; Suppuration | 1988 |